查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1618829

兒科醫療保健市場：按治療、適應症和最終用戶分類 - 全球預測 2025-2030

Paediatric Healthcare Market by Treatment (Immunotherapy, Medications, Surgeries), Indication (Asthma & Allergies, Cardiac Disorders, Genetic Disorders), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年兒科醫療保健市場價值為1,070.1億美元，預計到2024年將達到1,145.5億美元，複合年成長率為7.53%，到2030年將達到1,779.4億美元。

兒科醫療保健市場涵蓋各種針對從新生兒到青少年的兒童獨特醫療需求的服務。這個領域至關重要，因為它解決了與成人截然不同的特定發展、營養和社會心理需求。兒科醫療保健不僅限於治療，還包括預防保健、診斷和治療性介入，最終用途包括醫院、診所和專科醫療中心。主要成長要素包括醫療設備和藥品的技術進步、兒童健康意識的提高以及兒童疾病的增加。由於便利性和可近性的提高，對遠端醫療的需求激增，為相關人員提供了有利可圖的機會。此外，小兒科對慢性疾病的深入研究為技術創新提供了巨大的潛力。然而，嚴格的法律規範、先進醫療保健解決方案的高成本以及獲得優質醫療設施的差異等挑戰正在阻礙市場成長。該行業必須應對這些挑戰，特別是倡導全面和支持性的醫療保健政策。創新應著重於開發具有成本效益的醫療設備，並為服務不足的人增強遠端醫療解決方案。此外，將人工智慧 (AI) 納入診斷和患者管理系統可以增強個人化護理。為了實現業務成長，明智的做法是投資兒科疫苗開發，特別是針對快速成長的病毒威脅，並探索與高科技公司合作開發智慧健康解決方案。此外，開發適合兒科的穿戴式健康技術以持續監測健康指標並促進預防性健康管理具有巨大潛力。從本質上講，兒科醫療保健市場競爭激烈，但前景廣闊，其特點是不斷的研究和改善全球兒童健康的強大動力。為了利用這些動態，公司必須優先考慮創新和策略聯盟，同時了解技術趨勢和監管變化。

主要市場統計
基準年[2023] 1070.1億美元
預計年份 [2024] 1145.5億美元
預測年份 [2030] 1779.4億美元
複合年成長率（%） 7.53%

市場動態：揭示快速發展的兒科醫療保健市場的關鍵市場洞察

供需的動態交互作用正在改變兒科醫療保健市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 病毒感染和營養不良導致的死亡人數增加
    • 增加政府支持和舉措以促進兒童健康
    • 提高家長對適當治療的認知
  • 市場限制因素
    • 倫理問題和研究參與者人數較少
  • 市場機會
    • 技術進步中研發不斷上升
    • 新興國家醫療費用快速上漲
  • 市場挑戰
    • 全球小兒科短缺

波特五力：駕馭兒科醫療市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解兒科醫療保健市場的外部影響

外部宏觀環境因素在塑造兒科醫療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解兒科醫療市場的競爭格局

對兒科醫療保健市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 兒科醫療保健市場定位矩陣供應商績效評估

FPNV定位矩陣是評估兒科醫療保健市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製兒科醫療保健市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，兒科醫療保健市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 病毒感染和營養不良導致的死亡人數增加
      • 加大政府支持並努力促進兒童健康
      • 家長尋求適當治療的意識不斷增強
    • 抑制因素
      • 倫理問題和研究對象數量較少
    • 機會
      • 擴大技術進步的研究和開發
      • 新興國家醫療費用快速上漲
    • 任務
      • 全球小兒科短缺
  • 市場區隔分析
    • 治療：擴大兒科醫療保健的覆蓋範圍，以針對各種健康狀況進行免疫治療
    • 適應症：兒科醫療保健領域對有效、適合年齡的藥物來控制氣喘和過敏的需求不斷成長。
    • 最終用戶：在提供廣泛服務的醫院和診所中擴大使用兒科醫療保健
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 依治療分類的兒科醫療市場

  • 免疫療法
  • 藥品
  • 外科手術

第7章兒科醫療市場（按適應症）

  • 氣喘和過敏
  • 心臟病
  • 遺傳疾病
  • 代謝紊亂

第8章兒科醫療保健市場：依最終用戶分類

  • 門診治療中心
  • 家庭護理設置
  • 醫院/診所

第9章美洲兒科醫療保健市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區兒科醫療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲兒科醫療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Cortica 在新資金籌措中籌集 7,500 萬美元並收購 Springtide Child Development
    • 兒科行為健康提供者 Bend Health 獲得 3,200 萬美元資金籌措
    • Ipsen 收購 Albireo 以加速小兒肝病治療罕見疾病領域的成長
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • AstraZeneca PLC
  • Aveanna Healthcare, LLC.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Boehringer Ingelheim International GmbH
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Enviva Inc.
  • Gilead Sciences, Inc.
  • Glaxosmithkline PLC
  • GP Pharm, SA
  • Henin Lukinz Pvt. Ltd.
  • Interim HealthCare Inc.
  • Janssen Global Services LLC
  • Johnson & Johnson Services, Inc.
  • Medexus Pharmaceuticals, Inc.
  • Medtronic PLC
  • Merck KGaA
  • Novartis AG
  • Olympus Corporation
  • ORPHELIA Pharma
  • Pfizer Inc.
  • Proveca Ltd.
  • Royal Philips
  • Sanofi SA
  • Siemens AG
  • Strykar Corporation
  • The Procter & Gamble Company
  • Thermo Fisher Scientific, Inc.
  • Viatris Inc.
Product Code: MRR-434CCDA04E27

The Paediatric Healthcare Market was valued at USD 107.01 billion in 2023, expected to reach USD 114.55 billion in 2024, and is projected to grow at a CAGR of 7.53%, to USD 177.94 billion by 2030.

The pediatric healthcare market encompasses various services tailored to the unique medical needs of children, from newborns to adolescents. This sector is essential because it addresses specific developmental, nutritional, and psychosocial requirements that are vastly different from adults. Pediatric healthcare extends beyond treatment to preventive care, diagnostics, and therapeutic interventions, with end-use involving hospitals, clinics, and specialty care centers. Key growth influencers include technological advancements in medical devices and pharmaceuticals, rising awareness of child health, and increasing incidences of pediatric diseases. The surge in demand for telemedicine, owing to convenience and enhanced accessibility, presents a lucrative opportunity for stakeholders. Additionally, the thriving focus on pediatric research for chronic illnesses offers significant potential for innovation. However, challenges like stringent regulatory frameworks, high costs of advanced healthcare solutions, and disparities in access to quality healthcare facilities pose obstacles to market growth. The industry must address these challenges, notably by advocating for more inclusive and supportive healthcare policies. Innovation should focus on developing cost-effective medical devices and enhancing telehealth solutions to reach underserved populations. Furthermore, the integration of artificial intelligence (AI) in diagnostics and patient management systems can enhance personalized care. For business growth, investing in pediatric vaccine development, especially for emergent viral threats, and exploring partnerships with tech companies for smart-health solutions can be prudent. Additionally, there is considerable potential in developing wearable health technology adapted for children to monitor health metrics continuously, thus fostering proactive health management. In nature, the pediatric healthcare market is competitive yet promising, characterized by ongoing research and a strong drive towards better health outcomes for children globally. To harness these dynamics, companies should remain updated on technological trends and regulatory changes while prioritizing innovation and strategic collaborations.

KEY MARKET STATISTICS
Base Year [2023] USD 107.01 billion
Estimated Year [2024] USD 114.55 billion
Forecast Year [2030] USD 177.94 billion
CAGR (%) 7.53%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Paediatric Healthcare Market

The Paediatric Healthcare Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of deaths attributed to viral infections and malnutrition
    • Rising government support and initiatives to promote pediatric health
    • Growing awareness among child parents for adequate treatment
  • Market Restraints
    • Ethical concerns and small size of the study population
  • Market Opportunities
    • Growing research and development in technological advancements
    • Surge in medical expenditure in emerging economies
  • Market Challenges
    • Lack of pediatricians across the globe

Porter's Five Forces: A Strategic Tool for Navigating the Paediatric Healthcare Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Paediatric Healthcare Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Paediatric Healthcare Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Paediatric Healthcare Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Paediatric Healthcare Market

A detailed market share analysis in the Paediatric Healthcare Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Paediatric Healthcare Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Paediatric Healthcare Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Paediatric Healthcare Market

A strategic analysis of the Paediatric Healthcare Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Paediatric Healthcare Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca PLC, Aveanna Healthcare, LLC., Becton, Dickinson and Company, bioMerieux SA, Boehringer Ingelheim International GmbH, Eisai Co., Ltd., Eli Lilly and Company, Enviva Inc., Gilead Sciences, Inc., Glaxosmithkline PLC, GP Pharm, S.A., Henin Lukinz Pvt. Ltd., Interim HealthCare Inc., Janssen Global Services LLC, Johnson & Johnson Services, Inc., Medexus Pharmaceuticals, Inc., Medtronic PLC, Merck KGaA, Novartis AG, Olympus Corporation, ORPHELIA Pharma, Pfizer Inc., Proveca Ltd., Royal Philips, Sanofi S.A, Siemens AG, Strykar Corporation, The Procter & Gamble Company, Thermo Fisher Scientific, Inc., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Paediatric Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment, market is studied across Immunotherapy, Medications, and Surgeries.
  • Based on Indication, market is studied across Asthma & Allergies, Cardiac Disorders, Genetic Disorders, and Metabolic Disorders.
  • Based on End-User, market is studied across Ambulatory Care Centers, Homecare Settings, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of deaths attributed to viral infections and malnutrition
      • 5.1.1.2. Rising government support and initiatives to promote pediatric health
      • 5.1.1.3. Growing awareness among child parents for adequate treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Ethical concerns and small size of the study population
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing research and development in technological advancements
      • 5.1.3.2. Surge in medical expenditure in emerging economies
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of pediatricians across the globe
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment: Expanding usage of pediatric healthcare for immunotherapy for a myriad of health conditions
    • 5.2.2. Indication: Growing need for effective, age-appropriate medications in pediatric healthcare to manage asthma & allergies
    • 5.2.3. End-User: Growing usage of pediatric healthcare across hospitals & clinics that offer a wide range of services
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Paediatric Healthcare Market, by Treatment

  • 6.1. Introduction
  • 6.2. Immunotherapy
  • 6.3. Medications
  • 6.4. Surgeries

7. Paediatric Healthcare Market, by Indication

  • 7.1. Introduction
  • 7.2. Asthma & Allergies
  • 7.3. Cardiac Disorders
  • 7.4. Genetic Disorders
  • 7.5. Metabolic Disorders

8. Paediatric Healthcare Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Care Centers
  • 8.3. Homecare Settings
  • 8.4. Hospitals & Clinics

9. Americas Paediatric Healthcare Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Paediatric Healthcare Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Paediatric Healthcare Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Cortica Closes USD 75 Million in New Funding Round and Acquires Springtide Child Development
    • 12.3.2. Pediatric Behavioral Health Provider Bend Health Moves Out of Stealth Mode with USD 32M in Funding
    • 12.3.3. Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AstraZeneca PLC
  • 3. Aveanna Healthcare, LLC.
  • 4. Becton, Dickinson and Company
  • 5. bioMerieux SA
  • 6. Boehringer Ingelheim International GmbH
  • 7. Eisai Co., Ltd.
  • 8. Eli Lilly and Company
  • 9. Enviva Inc.
  • 10. Gilead Sciences, Inc.
  • 11. Glaxosmithkline PLC
  • 12. GP Pharm, S.A.
  • 13. Henin Lukinz Pvt. Ltd.
  • 14. Interim HealthCare Inc.
  • 15. Janssen Global Services LLC
  • 16. Johnson & Johnson Services, Inc.
  • 17. Medexus Pharmaceuticals, Inc.
  • 18. Medtronic PLC
  • 19. Merck KGaA
  • 20. Novartis AG
  • 21. Olympus Corporation
  • 22. ORPHELIA Pharma
  • 23. Pfizer Inc.
  • 24. Proveca Ltd.
  • 25. Royal Philips
  • 26. Sanofi S.A
  • 27. Siemens AG
  • 28. Strykar Corporation
  • 29. The Procter & Gamble Company
  • 30. Thermo Fisher Scientific, Inc.
  • 31. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. PAEDIATRIC HEALTHCARE MARKET RESEARCH PROCESS
  • FIGURE 2. PAEDIATRIC HEALTHCARE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PAEDIATRIC HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PAEDIATRIC HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PAEDIATRIC HEALTHCARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PAEDIATRIC HEALTHCARE MARKET DYNAMICS
  • TABLE 7. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ASTHMA & ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY CARDIAC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. PAEDIATRIC HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. PAEDIATRIC HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023